S-4 Filing

ELANCO ANIMAL HEALTH INC CIK: 1739104

Filing Information

Form Type	S-4
Accession Number	`0001047469-19-000413`
Period End Date	20180930
Filing Date	20190208
Fiscal Year	N/A
Fiscal Period	N/A
XBRL Instance	elan-20190208.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 85 Income Statement 65 Cash Flow Statement 109 Stockholders Equity 27 Comprehensive Income 15

Balance Sheet 85 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowances	`AllowanceForDoubtfulAccountsReceivableCurrent`	$8.80M	USD	Point-in-time
Accounts receivable, allowances	`AllowanceForDoubtfulAccountsReceivableCurrent`	$11.00M	USD	Point-in-time
Accounts receivable, allowances	`AllowanceForDoubtfulAccountsReceivableCurrent`	$9.80M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$300.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$323.40M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$258.80M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$343.60M	USD	Point-in-time
Accounts receivable, net of allowances of $8.8 (2018) and $9.8 (2017)	`AccountsReceivableNetCurrent`	$585.00M	USD	Point-in-time
Accounts receivable, net of allowances of $8.8 (2018) and $9.8 (2017)	`AccountsReceivableNetCurrent`	$567.40M	USD	Point-in-time
Accounts receivable, net of allowances of $8.8 (2018) and $9.8 (2017)	`AccountsReceivableNetCurrent`	$606.10M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$30.80M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$45.70M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$34.50M	USD	Point-in-time
Inventories (Note 6)	`InventoryNet`	$875.60M	USD	Point-in-time
Inventories (Note 6)	`InventoryNet`	$1.06B	USD	Point-in-time
Inventories (Note 6)	`InventoryNet`	$1.01B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$136.10M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$123.20M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$182.30M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.95B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.12B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.70B	USD	Point-in-time
Investments (Note 9)	`Investments`	$12.30M	USD	Point-in-time
Investments (Note 9)	`Investments`	$9.00M	USD	Point-in-time
Investments (Note 9)	`Investments`	$14.90M	USD	Point-in-time
Goodwill (Note 8)	`Goodwill`	$2.97B	USD	Point-in-time
Goodwill (Note 8)	`Goodwill`	$2.58B	USD	Point-in-time
Goodwill (Note 8)	`Goodwill`	$2.97B	USD	Point-in-time
Other intangibles, net (Note 8)	`IntangibleAssetsNetExcludingGoodwill`	$2.67B	USD	Point-in-time
Other intangibles, net (Note 8)	`IntangibleAssetsNetExcludingGoodwill`	$2.62B	USD	Point-in-time
Other intangibles, net (Note 8)	`IntangibleAssetsNetExcludingGoodwill`	$2.51B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$204.00M	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$242.00M	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$100.00M	USD	Point-in-time
Property and equipment, net (Note 9)	`PropertyPlantAndEquipmentNet`	$741.80M	USD	Point-in-time
Property and equipment, net (Note 9)	`PropertyPlantAndEquipmentNet`	$920.30M	USD	Point-in-time
Property and equipment, net (Note 9)	`PropertyPlantAndEquipmentNet`	$909.30M	USD	Point-in-time
Total assets	`Assets`	$9.21B	USD	Point-in-time
Total assets	`Assets`	$8.10B	USD	Point-in-time
Total assets	`Assets`	$8.94B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$202.70M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$203.80M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$228.20M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$81.30M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$83.20M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$89.30M	USD	Point-in-time
Sales rebates and discounts	`ContractWithCustomerLiabilityCurrent`	$165.50M	USD	Point-in-time
Sales rebates and discounts	`ContractWithCustomerLiabilityCurrent`	$147.90M	USD	Point-in-time
Sales rebates and discounts	`ContractWithCustomerLiabilityCurrent`	$159.10M	USD	Point-in-time
Income taxes payable (Note 11)	`AccruedIncomeTaxesCurrent`	$4.80M	USD	Point-in-time
Income taxes payable (Note 11)	`AccruedIncomeTaxesCurrent`	$7.50M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$184.50M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$178.60M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$151.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.25B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$643.10M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$629.40M	USD	Point-in-time
Accrued retirement benefits (Note 12)	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$136.00M	USD	Point-in-time
Accrued retirement benefits (Note 12)	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$139.00M	USD	Point-in-time
Accrued retirement benefits (Note 12)	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$113.80M	USD	Point-in-time
Deferred taxes (Note 11)	`DeferredIncomeTaxLiabilitiesNet`	$251.90M	USD	Point-in-time
Deferred taxes (Note 11)	`DeferredIncomeTaxLiabilitiesNet`	$227.50M	USD	Point-in-time
Deferred taxes (Note 11)	`DeferredIncomeTaxLiabilitiesNet`	$125.00M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$111.60M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$89.50M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$126.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.16B	USD	Point-in-time
Total liabilities	`Liabilities`	$4.07B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.08B	USD	Point-in-time
Net parent company investment	`ParentCompanyInvestmentNet`	$7.47B	USD	Point-in-time
Net parent company investment	`ParentCompanyInvestmentNet`	$8.04B	USD	Point-in-time
Accumulated other comprehensive loss (Note 14)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-221.90M	USD	Point-in-time
Accumulated other comprehensive loss (Note 14)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-66.50M	USD	Point-in-time
Accumulated other comprehensive loss (Note 14)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-456.90M	USD	Point-in-time
Accumulated other comprehensive loss (Note 14)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-256.60M	USD	Point-in-time
Accumulated other comprehensive loss (Note 14)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-210.30M	USD	Point-in-time
Total equity	`StockholdersEquity`	$2.43B	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.14B	USD	Point-in-time
Total equity	`StockholdersEquity`	$7.78B	USD	Point-in-time
Total equity	`StockholdersEquity`	$7.43B	USD	Point-in-time
Total equity	`StockholdersEquity`	$7.02B	USD	Point-in-time
Total equity	`StockholdersEquity`	$7.96B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$8.10B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$8.94B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$9.21B	USD	Point-in-time

Income Statement 65 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.13B	USD	3 Qtrs
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.89B	USD	Annual
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.27B	USD	3 Qtrs
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.91B	USD	Annual
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.91B	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$1.09B	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$1.16B	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$1.49B	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$1.53B	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$1.41B	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$189.70M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$291.00M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$251.70M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$185.50M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$265.80M	USD	Annual
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$916.00M	USD	Annual
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$784.80M	USD	Annual
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$583.00M	USD	3 Qtrs
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$779.80M	USD	Annual
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$550.10M	USD	3 Qtrs
Amortization of intangible assets (Note 8)	`AmortizationOfIntangibleAssets`	$221.20M	USD	Annual
Amortization of intangible assets (Note 8)	`AmortizationOfIntangibleAssets`	$163.00M	USD	Annual
Amortization of intangible assets (Note 8)	`AmortizationOfIntangibleAssets`	$170.70M	USD	Annual
Amortization of intangible assets (Note 8)	`AmortizationOfIntangibleAssets`	$147.30M	USD	3 Qtrs
Amortization of intangible assets (Note 8)	`AmortizationOfIntangibleAssets`	$161.00M	USD	3 Qtrs
Asset impairment, restructuring and other special charges (Note 5)	`RestructuringSettlementAndImpairmentProvisions`	$263.30M	USD	Annual
Asset impairment, restructuring and other special charges (Note 5)	`RestructuringSettlementAndImpairmentProvisions`	$82.80M	USD	3 Qtrs
Asset impairment, restructuring and other special charges (Note 5)	`RestructuringSettlementAndImpairmentProvisions`	$308.40M	USD	Annual
Asset impairment, restructuring and other special charges (Note 5)	`RestructuringSettlementAndImpairmentProvisions`	$375.10M	USD	Annual
Asset impairment, restructuring and other special charges (Note 5)	`RestructuringSettlementAndImpairmentProvisions`	$189.30M	USD	3 Qtrs
Other - net, (income) expense	`NonoperatingIncomeExpense`	$100.00K	USD	Annual
Other - net, (income) expense	`NonoperatingIncomeExpense`	$-24.20M	USD	3 Qtrs
Other - net, (income) expense	`NonoperatingIncomeExpense`	$-1.60M	USD	Annual
Other - net, (income) expense	`NonoperatingIncomeExpense`	-	USD	3 Qtrs
Other - net, (income) expense	`NonoperatingIncomeExpense`	$2.80M	USD	Annual
Costs, expenses and other	`CostsAndExpenses`	$2.94B	USD	Annual
Costs, expenses and other	`CostsAndExpenses`	$2.21B	USD	3 Qtrs
Costs, expenses and other	`CostsAndExpenses`	$2.15B	USD	3 Qtrs
Costs, expenses and other	`CostsAndExpenses`	$3.12B	USD	Annual
Costs, expenses and other	`CostsAndExpenses`	$3.17B	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-22.40M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-232.60M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-259.50M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$116.30M	USD	3 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-77.20M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$72.00M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$46.20M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$-48.70M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$25.50M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$78.10M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-149.20M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-210.80M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-47.90M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-310.70M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$70.10M	USD	3 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.06	USD	Annual
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.51	USD	3 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$0.24	USD	3 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.16	USD	Annual
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.72	USD	Annual
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	293.30M	shares	3 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	296.20M	shares	3 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	293.30M	shares	Annual
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	293.30M	shares	Annual
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	293.30M	shares	Annual

Cash Flow Statement 109 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-149.20M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-210.80M	USD	Annual
Net loss	`NetIncomeLoss`	$-47.90M	USD	Annual
Net loss	`NetIncomeLoss`	$-310.70M	USD	Annual
Net loss	`NetIncomeLoss`	$70.10M	USD	3 Qtrs
Depreciation, Depletion and Amortization	`DepreciationDepletionAndAmortization`	$318.40M	USD	Annual
Depreciation, Depletion and Amortization	`DepreciationDepletionAndAmortization`	$231.30M	USD	3 Qtrs
Depreciation, Depletion and Amortization	`DepreciationDepletionAndAmortization`	$254.40M	USD	Annual
Depreciation, Depletion and Amortization	`DepreciationDepletionAndAmortization`	$236.90M	USD	Annual
Depreciation, Depletion and Amortization	`DepreciationDepletionAndAmortization`	$222.30M	USD	3 Qtrs
Deferred Income Tax Expense (Benefit)	`DeferredIncomeTaxExpenseBenefit`	$12.60M	USD	3 Qtrs
Deferred Income Tax Expense (Benefit)	`DeferredIncomeTaxExpenseBenefit`	$-7.00M	USD	3 Qtrs
Deferred Income Tax Expense (Benefit)	`DeferredIncomeTaxExpenseBenefit`	$-13.40M	USD	Annual
Deferred Income Tax Expense (Benefit)	`DeferredIncomeTaxExpenseBenefit`	$-76.20M	USD	Annual
Deferred Income Tax Expense (Benefit)	`DeferredIncomeTaxExpenseBenefit`	$-5.90M	USD	Annual
Share-based Compensation	`ShareBasedCompensation`	$20.40M	USD	Annual
Share-based Compensation	`ShareBasedCompensation`	$18.70M	USD	3 Qtrs
Share-based Compensation	`ShareBasedCompensation`	$13.40M	USD	Annual
Share-based Compensation	`ShareBasedCompensation`	$25.00M	USD	Annual
Share-based Compensation	`ShareBasedCompensation`	$20.20M	USD	3 Qtrs
Asset impairment charges	`AssetImpairmentChargesIncludingInventoryWriteDown`	$102.50M	USD	3 Qtrs
Asset impairment charges	`AssetImpairmentChargesIncludingInventoryWriteDown`	$110.60M	USD	Annual
Asset impairment charges	`AssetImpairmentChargesIncludingInventoryWriteDown`	$43.80M	USD	3 Qtrs
Asset impairment charges	`AssetImpairmentChargesIncludingInventoryWriteDown`	$98.30M	USD	Annual
Asset impairment charges	`AssetImpairmentChargesIncludingInventoryWriteDown`	$57.50M	USD	Annual
Gain on sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	3 Qtrs
Gain on sale of assets	`GainLossOnDispositionOfAssets1`	$19.60M	USD	Annual
Gain on sale of assets	`GainLossOnDispositionOfAssets1`	$16.00M	USD	3 Qtrs
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$3.50M	USD	3 Qtrs
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$2.80M	USD	3 Qtrs
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$6.00M	USD	Annual
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$1.50M	USD	Annual
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$10.00M	USD	Annual
Receivables - (increase) decrease	`IncreaseDecreaseInAccountsReceivable`	$80.70M	USD	Annual
Receivables - (increase) decrease	`IncreaseDecreaseInAccountsReceivable`	$-48.40M	USD	Annual
Receivables - (increase) decrease	`IncreaseDecreaseInAccountsReceivable`	$94.60M	USD	Annual
Inventories - (increase) decrease	`IncreaseDecreaseInInventories`	$-14.90M	USD	Annual
Inventories - (increase) decrease	`IncreaseDecreaseInInventories`	$89.10M	USD	Annual
Inventories - (increase) decrease	`IncreaseDecreaseInInventories`	$39.00M	USD	Annual
Other assets - (increase) decrease	`IncreaseDecreaseInOtherOperatingAssets`	$52.40M	USD	Annual
Other assets - (increase) decrease	`IncreaseDecreaseInOtherOperatingAssets`	$36.70M	USD	Annual
Other assets - (increase) decrease	`IncreaseDecreaseInOtherOperatingAssets`	$-52.50M	USD	Annual
Accounts payable and other liabilities - increase (decrease)	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$37.10M	USD	Annual
Accounts payable and other liabilities - increase (decrease)	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$116.40M	USD	Annual
Accounts payable and other liabilities - increase (decrease)	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-8.40M	USD	Annual
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$347.80M	USD	3 Qtrs
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$173.80M	USD	Annual
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$167.10M	USD	3 Qtrs
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$6.60M	USD	Annual
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$155.90M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$31.70M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$74.30M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$110.30M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$98.60M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$100.10M	USD	Annual
Disposals of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$7.40M	USD	Annual
Disposals of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$20.30M	USD	Annual
Disposals of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$37.60M	USD	Annual
Proceeds from sale of product rights (Note 4)	`ProceedsFromSaleOfProductRights`	$410.00M	USD	Annual
Cash paid for acquisitions, net of cash acquired (Note 4)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$5.28B	USD	Annual
Cash paid for acquisitions, net of cash acquired (Note 4)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$45.00M	USD	Annual
Cash paid for acquisitions, net of cash acquired (Note 4)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$882.10M	USD	3 Qtrs
Cash paid for acquisitions, net of cash acquired (Note 4)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Cash paid for acquisitions, net of cash acquired (Note 4)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$882.10M	USD	Annual
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$42.50M	USD	Annual
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$21.50M	USD	Annual
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$4.60M	USD	3 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$15.30M	USD	3 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$34.20M	USD	Annual
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-964.60M	USD	Annual
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-929.10M	USD	3 Qtrs
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-78.90M	USD	3 Qtrs
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-5.00B	USD	Annual
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-182.10M	USD	Annual
Net transactions with Lilly	`ProceedsFromPaymentsToTransactionsWithParent`	$-247.40M	USD	3 Qtrs
Net transactions with Lilly	`ProceedsFromPaymentsToTransactionsWithParent`	$844.00M	USD	3 Qtrs
Net transactions with Lilly	`ProceedsFromPaymentsToTransactionsWithParent`	$848.30M	USD	Annual
Net transactions with Lilly	`ProceedsFromPaymentsToTransactionsWithParent`	$5.35B	USD	Annual
Net transactions with Lilly	`ProceedsFromPaymentsToTransactionsWithParent`	$-149.60M	USD	Annual
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-500.00K	USD	3 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-800.00K	USD	Annual
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-3.70M	USD	3 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-149.60M	USD	Annual
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$843.50M	USD	3 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$5.35B	USD	Annual
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$327.20M	USD	3 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$847.50M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-19.80M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-26.00M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.30M	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.90M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.40M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$84.80M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$344.60M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$611.50M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-201.80M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$64.60M	USD	Annual
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$934.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$460.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$258.80M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$116.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$343.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$323.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$934.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$460.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$258.80M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$116.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$343.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$323.40M	USD	Point-in-time

Stockholders Equity 27 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period	`StockholdersEquity`	$2.43B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$5.14B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$7.78B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$7.43B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$7.02B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$7.96B	USD	Point-in-time
Net loss	`NetIncomeLoss`	$-149.20M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-210.80M	USD	Annual
Net loss	`NetIncomeLoss`	$-47.90M	USD	Annual
Net loss	`NetIncomeLoss`	$-310.70M	USD	Annual
Net loss	`NetIncomeLoss`	$70.10M	USD	3 Qtrs
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$200.30M	USD	Annual
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-155.40M	USD	Annual
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$231.80M	USD	3 Qtrs
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-235.00M	USD	Annual
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-9.80M	USD	3 Qtrs
Transfers (to)/from Lilly, net	`StockholdersEquityTransfersToFromParent`	$-129.20M	USD	Annual
Transfers (to)/from Lilly, net	`StockholdersEquityTransfersToFromParent`	$-226.30M	USD	3 Qtrs
Transfers (to)/from Lilly, net	`StockholdersEquityTransfersToFromParent`	$862.70M	USD	3 Qtrs
Transfers (to)/from Lilly, net	`StockholdersEquityTransfersToFromParent`	$873.30M	USD	Annual
Transfers (to)/from Lilly, net	`StockholdersEquityTransfersToFromParent`	$5.37B	USD	Annual
Balance at end of period	`StockholdersEquity`	$2.43B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$5.14B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$7.78B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$7.43B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$7.02B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$7.96B	USD	Point-in-time

Comprehensive Income 15 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-149.20M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-210.80M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-47.90M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-310.70M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$70.10M	USD	3 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$200.30M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-155.40M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$231.80M	USD	3 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-235.00M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-9.80M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-110.40M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-366.20M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$82.60M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-282.90M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$60.30M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.